Inactivated Vaccines Market on Track for Strong Growth, Estimated to Grow at 4.5% CAGR Through 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Inactivated Vaccines Market Through 2025?
Over the past few years, there has been a steady expansion in the size of the inactivated vaccines market. Rising from $6.19 billion in 2024, it is forecasted to reach $6.37 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 2.8%. The notable growth within the historical period can be credited to factors such as efforts towards polio eradication, influenza vaccination initiatives, the emergence of infectious diseases, and regulatory approvals.

What's the Projected Size of the Global Inactivated Vaccines Market by 2029?
The market size of inactivated vaccines is predicted to experience consistent expansion in the upcoming years, reaching a value of "$7.58 billion in 2029 with an annual growth rate of 4.5%. This growth during the projection period can be credited to the preparedness for pandemics, enlarged vaccine coverage, progress in biomanufacturing, and initiatives towards health equity. Noteworthy trends anticipated during the forecast period encompass mRNA vaccine platforms, combination vaccines, thermostable vaccines, and digital vaccine passports.

View the full report here:
https://www.thebusinessresearchcompany.com/report/inactivated-vaccines-global-market-report

Top Growth Drivers in the Inactivated Vaccines Industry: What's Accelerating the Market?
The rise in the occurrence of infectious diseases is set to fuel the expansion of the inactivated vaccine market in the future. Infectious diseases are conditions instigated by pathogens such as bacteria, viruses, parasites, or fungi that can be transmitted between individuals, leading to a variety of symptoms and health issues. One such disease is tuberculosis. The inactivated vaccines, which use non-viable pathogens to trigger an immune response, can effectively prevent ailments like polio, hepatitis A, and influenza. For example, a report from the Centers for Disease Control and Prevention in November 2023, a US public health institute, revealed a rise in tuberculosis cases from 8,320 in 2022 to 9,615 in 2023, an increase of 1,295 instances. Hence, the surging occurrences of infectious diseases are steering the growth of the inactivated vaccine market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13018&type=smp

What Are the Key Trends Driving Inactivated Vaccines Market Growth?
Major firms in the inactivated vaccines market are maintaining their market stature by launching innovative inactivated vaccines. Such vaccines consist of inactivated pathogens such as viruses or bacteria that were grown in culture and subsequently destroyed to terminate their ability to produce disease. For example, in January 2022, GSK PLC, a pharmaceutical and biotechnology firm based in the UK, debuted a new inactivated shingles vaccine named Shingrix. Shingrix, an adjuvanted non-live recombinant subunit vaccine given in two intramuscular doses, was initially made for those aged 50 and above. However, it now covers individuals aged 18 and above who are at a greater risk of shingles due to immunodeficiency or immunosuppression resulting from a known medical condition or therapy.

What Are the Main Segments in the Inactivated Vaccines Market?
The inactivated vaccines market covered in this report is segmented -

1) By Type: Viral Vaccine, Bacterial Vaccine
2) By Method Of Inactivation: Solvent Detergent, Radiation, pH Concentration, Heat Inactivation, Other Methods Of Inactivation
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels

Subsegments:
1) By Viral Vaccine: Inactivated Poliovirus Vaccine (IPV), Inactivated Influenza Vaccine, Inactivated Hepatitis A Vaccine, Inactivated Rabies Vaccine
2) By Bacterial Vaccine: Inactivated Typhoid Vaccine, Inactivated Cholera Vaccine, Inactivated Pertussis Vaccine, Inactivated Plague Vaccine

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13018&type=smp

Which Top Companies are Driving Growth in the Inactivated Vaccines Market?
Major companies operating in the inactivated vaccines market are Pfizer Inc., Johnson & Johnson Services Inc., Sinopharm Group Co. Ltd., Merck & Co. Inc., Sanofi S.A., GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., CSL Limited, Daiichi Sankyo Company Limited, Mitsubishi Tanabe Pharma Corporation, Novavax Inc., Zydus Lifesciences Ltd., Sinovac Biotech Ltd., Biological E Limited, Hualan Biological Engineering Inc., CanSino Biologics Inc., Shenzhen Kangtai Biological Products Co. Ltd., Serum Institute of India Pvt. Ltd., Beijing Tiatan Biological Products Co. Ltd., Valneva SE, Bavarian Nordic A/S., Beijing Minhai Biotechnology Co. Ltd., Bharat Biotech International Limited, Panacea Biotec Ltd., Sinergium Biotech SA, Bharat Immunologicals and Biologicals Corporation Limited, Haffkine Biopharmaceutical Corporation Limited, Incepta Vaccine Ltd., Changchun BCHT Biotechnology Co. Ltd., .

Which Regions Will Dominate the Inactivated Vaccines Market Through 2029?
North America was the largest region in the inactivated vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in inactivated vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13018

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.